Using SpliceAI to triage splice-altering variants in 7,220 individuals with rare conditions highlights limitations of the precomputed scores
Alexandra C Martin-GearyiD, François LecoquierreiD, Susan WalkeriD, Nicola WhiffiniD, Ruebena DawesiD
Abstract
BackgroundSpliceAI is a deep learning algorithm that predicts whether genetic variants are likely to affect splicing. Precomputed spliceAI predictions for all theoretical SNVs and small indels were released in 2019, and are used by variant annotation tools such as VEP and dbNSFP to batch annotate large numbers of variants quickly. While the use of precomputed scores vastly reduces the computational cost of retrieving spliceAI predictions, several limitations to their utility have emerged, for which the impact on the prioritisation of likely splice-altering variants in cohort studies has not been established. MethodsWe identify annotation and liftover errors present in the precomputed SpliceAI scores by comparing the original gene annotation file with MANE v1.0 Select transcripts. To quantify the impact that these factors may have in variant prioritisation pipelines for diagnostic purposes, we re-analysed variants in 660 genes linked to neurodevelopmental disorders (NDD), identified in 7,221 participants with NDD from the Genomics England 100,000 Genomes Project (100kGP). ResultsWe find outdated gene annotations and liftover errors impact 8.34% of theoretical SNVs included in the SpliceAI precomputed scores, and affect accuracy of SpliceAI predictions in 34.98% of disease-associated panelApp green genes. In 7,221 Genomics England participants, re-running SpliceAI with optimised parameters results in an increase of 18.2% predicted splice-altering variants compared with variants identified using precomputed scores alone. These variants constitute a diagnostic increase of 11.7% versus the precomputed scores, assessed retrospectively using confirmed diagnoses in 100kGP. In addition we identify a new diagnostic candidate (chr10:129963548:CCGGTGAG:C) in a participant with Ataxia which would be missed by the precomputed scores. To mitigate issues with the precomputed scores we provide SpliceAI-splint- a command-line tool to allow users to identify variants within a VCF file whose potential splice-altering effects would be missed by the precomputed scores. ConclusionsWe find that although the precomputed scores continue to represent a useful resource in the annotation of variants in cohorts with genetic disorders, we find key limitations that can lead to their missing clinically relevant splice-altering variants, and provide a command-line tool to mitigate these issues.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 3.93
- Field percentile
- top 14%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Benchmarking splice variant prediction algorithms using massively parallel splicing assays
Cathy Smith, Jacob Otto Kitzman·bioRxiv·May 4, 2023
- Analyzing the Performance of Deep Learning Splice Prediction Algorithms
Nathan Fortier, Gabe Rudy, Andreas Scherer·PLoS ONEPeer-reviewed·May 13, 2026
- A unified framework for quantitative splicing and transcript prediction
Kishore Jaganathan, Jianbin Chen, … Kyle Kai‐How Farh·bioRxiv·Oct 11, 2026
- Functional and in-silico interrogation of rare genomic variants impacting RNA splicing for the diagnosis of genomic disorders
Jamie M. Ellingford, Huw B. Thomas, … Graeme Charles M. Black·bioRxiv·Sep 26, 2019
- Predicting the impact of rare variants on RNA splicing in CAGI6
Jenny Lord, Carolina Jaramillo Oquendo, … Diana Baralle·Human GeneticsPeer-reviewed·Jan 3, 2024
- Benchmarking the AlphaGenome Variant Impact score against SpliceAI on post-release ClinVar classifications and experimental splicing assays
Ozge Ayse Cavus, Ayşegül Kuşkucu·bioRxiv·Oct 17, 2026